Prevalence and Factors Associated with Osteoporosis, Fracture and Sarcopenia Among Patients with Type 1 Diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20250424002

Enrollment

Registered

2025-04-24

Start date

2025-04-23

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

To investigate the prevalence of osteoporosis, sarcopenia and fracture in patients with T1DM Osteoporosis, sarcopenia, fracture, bone mineral density, type 1 diabetes

Interventions

Patients with diagnosed Type 1 Diabetes

Diagnostic

Type 1 Diabetes

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Diagnosed with Type 1 Diabetes Mellitus 2. Age over 18 years

Exclusion criteria

Exclusion criteria: 1. Pregnant patients 2. Patients with HIV infection 3. Patients taking medications that affect bone density or muscle mass, including corticosteroids, anabolic steroids, and bisphosphonate (except for calcium, vitamin D, anti-thyroid drugs, and levothyroxine)

Design outcomes

Primary

Measure	Time frame
Prevalence of osteoporosis at time of study collection DXA (Dual-energy X-ray absorptiometry) scan	—

Secondary

Measure	Time frame
Prevalence of sarcopenia at time of study collection Hand grip strength, 6-metre walk, Five times sit-to-stand test, Timed Up and Go test , DXA (Dual-energy X-ray absorptiometry) scan,Prevalence of fracture at time of study collection Vertebral fracture assessment (VFA), history	—

Countries

Thailand

Contacts

Public ContactJirawan Pongrujikorn

Chulalongkorn university

jirawanpongrujikorn@gmail.com022564101

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026